{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:27:19Z","timestamp":1789637239090,"version":"4.0.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Hoffmann-La Roche Inc."},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["GM61988"],"award-info":[{"award-number":["GM61988"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["ES07965"],"award-info":[{"award-number":["ES07965"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["AT007705"],"award-info":[{"award-number":["AT007705"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.tox.2015.02.007","type":"journal-article","created":{"date-parts":[[2015,2,24]],"date-time":"2015-02-24T14:54:29Z","timestamp":1424789669000},"page":"55-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Ontogenic expression of human carboxylesterase-2 and cytochrome P450 3A4 in liver and duodenum: Postnatal surge and organ-dependent regulation"],"prefix":"10.1016","volume":"330","author":[{"given":"Yi-Tzai","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynnie","family":"Trzoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongfang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingfang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2015.02.007_bib0005","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/dmd.105.007807","article-title":"Ontogeny of hepatic and plasma metabolism of deltamethrin in vitro: role in age-dependent acute neurotoxicity","volume":"34","author":"Anand","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2015.02.007_bib0010","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.2337\/diab.46.8.1319","article-title":"Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients","volume":"46","author":"Auboeuf","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.tox.2015.02.007_bib0015","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1634\/theoncologist.2010-0260","article-title":"Part 3: pharmacogenetic variability in phase II anticancer drug metabolism","volume":"16","author":"Deenen","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.tox.2015.02.007_bib0020","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1124\/dmd.105.005611","article-title":"Localization and mRNA expression of CYP3A and P-glycoprotein in human duodenum as a function of age","volume":"33","author":"Fakhoury","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2015.02.007_bib0025","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1124\/dmd.110.035956","article-title":"The intestine as an important contributor to prasugrel active metabolite formation in vivo","volume":"39","author":"Hagihara","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2015.02.007_bib0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijpharm.2012.05.079","article-title":"Developmental expression of drug metabolizing enzymes: impact on disposition in neonates and young children","volume":"452","author":"Hines","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.tox.2015.02.007_bib0035","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.cmet.2010.02.001","article-title":"Hepatic FGF21 expression is induced at birth via PPARalpha in response to milk intake and contributes to thermogenic activation of neonatal brown fat","volume":"11","author":"Hondares","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.tox.2015.02.007_bib0040","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0090-9556(25)08432-6","article-title":"Species differences in the induction of hepatic microsomal carboxylesterases caused by dietary exposure to di(2-ethylhexyl) phthalate a peroxisome proliferator","volume":"22","author":"Hosokawa","year":"1994","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2015.02.007_bib0045","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fgene.2013.00012","article-title":"Pharmacogenomics of cytochrome P450 3A4: recent progress toward the missing heritability problem","volume":"4","author":"Klein","year":"2013","journal-title":"Front. Genet."},{"key":"10.1016\/j.tox.2015.02.007_bib0050","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.2174\/0929867033456855","article-title":"Human cytochromes P450 associated with the phase 1 metabolism of drugs and other xenobiotics: a compilation of substrates and inhibitors of the CYP1 CYP2 and CYP3 families","volume":"10","author":"Lewis","year":"2003","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.tox.2015.02.007_bib0055","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1006\/taap.1999.8693","article-title":"Comparative neurochemical effects of repeated methyl parathion or chlorpyrifos exposures in neonatal and adult rats","volume":"158","author":"Liu","year":"1999","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2015.02.007_bib0060","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1042\/BJ20070613","article-title":"The far and distal enhancers in the CYP3A4 gene coordinates the proximal promoter in responding to the pregnane X receptor similarly but differentially to hepatocyte nuclear factor-4\u03b1","volume":"409","author":"Liu","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.tox.2015.02.007_bib0065","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1124\/dmd.112.050211","article-title":"RNA-sequencing quantification of hepatic ontogeny and tissue distribution of mRNAs of phase II enzymes in mice","volume":"41","author":"Lu","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2015.02.007_bib0070","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1006\/abbi.1994.1532","article-title":"Regulation of two rat liver microsomal carboxylesterase isozymes: species differences, tissue distribution and the effects of age sex and xenobiotic treatment of rats","volume":"315","author":"Morgan","year":"1994","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.tox.2015.02.007_bib0075","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1124\/dmd.105.008672","article-title":"The human intestinal cytochrome P450 pie","volume":"34","author":"Paine","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2015.02.007_bib0080","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1124\/dmd.109.027680","article-title":"MicroRNAs regulate CYP3A4 expression via direct and indirect targeting","volume":"37","author":"Pan","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2015.02.007_bib0085","first-page":"214","article-title":"Translational genomics in cancer research: converting profiles into personalized cancer medicine","volume":"10","author":"Patel","year":"2013","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.tox.2015.02.007_bib0090","first-page":"1548","article-title":"Cytochrome P450 Involvement in the biotransformation of cisapride and racemic norcisapride in vitro: differential activity of individual human CYP3A isoforms","volume":"29","author":"Pearce","year":"2001","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2015.02.007_bib0095","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1124\/dmd.113.054635","article-title":"RNA-sequencing quantification of hepatic ontogeny of phase-I enzymes in mice","volume":"41","author":"Peng","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2015.02.007_bib0100","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0300-483X(01)00416-4","article-title":"Altered expression of the carboxylesterases ES-4 and ES-10 by peroxisome proliferator chemicals","volume":"165","author":"Poole","year":"2001","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2015.02.007_bib0105","doi-asserted-by":"crossref","first-page":"e82562","DOI":"10.1371\/journal.pone.0082562","article-title":"Polymorphic cytochrome P450 enzymes (CYPs) and their role in personalized therapy","volume":"8","author":"Preissner","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.tox.2015.02.007_bib0110","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2174\/092986609789071324","article-title":"Human carboxylesterases: an update on CES1, CES2 and CES3","volume":"16","author":"Sanghani","year":"2009","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.tox.2015.02.007_bib0115","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1472-6939-14-55","article-title":"What is personalized medicine: sharpening a vague term based on a systematic literature review","volume":"14","author":"Schleidgen","year":"2013","journal-title":"BMC Med. Ethics"},{"key":"10.1016\/j.tox.2015.02.007_bib0120","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1006\/taap.1994.1106","article-title":"Age-dependent differences in the susceptibility of rats to deltamethrin","volume":"126","author":"Sheets","year":"1994","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2015.02.007_bib0125","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/infdis\/jiq145","article-title":"Surge in expression of carboxylesterase-1 during the post-natal stage enables a rapid gain of the capacity to activate the anti-influenza prodrug oseltamivir","volume":"203","author":"Shi","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tox.2015.02.007_bib0130","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.tiv.2005.06.045","article-title":"Pharmacogenetics of irinotecan metabolism and transport: an update","volume":"20","author":"Smith","year":"2006","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tox.2015.02.007_bib0135","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1124\/jpet.104.074971","article-title":"Simultaneous substitution of phenylalaine-305 and aspartate-318 of rat PXR by the corresponding human residues abolishes the ability to transactivate the cytochrome P4503A23 promoter","volume":"312","author":"Song","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2015.02.007_bib0140","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1740-8261.2009.01626.x","article-title":"Normal canine pediatric gastrointestinal ultrasonography","volume":"51","author":"Stander","year":"2010","journal-title":"Vet. Radiol. Ultrasound"},{"key":"10.1016\/j.tox.2015.02.007_bib0145","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/jcph.161","article-title":"Reduced exposure variability of the CYP3A substrate simvastatin by dose individualization to CYP3A activity","volume":"53","author":"Stoll","year":"2013","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.tox.2015.02.007_bib0150","doi-asserted-by":"crossref","first-page":"9674","DOI":"10.1074\/jbc.M709382200","article-title":"Post-transcriptional regulation of human pregnane X receptor by micro-RNA affects the expression of cytochrome P450 3A4","volume":"283","author":"Takagi","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tox.2015.02.007_bib0155","first-page":"2696","article-title":"Irinotecan activation by human carboxylesterases in colorectal adenocarcinoma cells","volume":"8","author":"Wu","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tox.2015.02.007_bib0160","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.bcp.2012.04.002","article-title":"Age-related inducibility of carboxylesterases by the antiepileptic agent phenobarbital and implications in drug metabolism and lipid accumulation","volume":"84","author":"Xiao","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2015.02.007_bib0165","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1124\/dmd.30.5.541","article-title":"Human and rodent carboxylesterases: immunorelatedness, overlapping substrate specificity, differential sensitivity to serine enzyme inhibitors, and tumor-related expression","volume":"30","author":"Xie","year":"2002","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2015.02.007_bib0170","doi-asserted-by":"crossref","first-page":"29688","DOI":"10.1016\/S0021-9258(18)43935-X","article-title":"Rat kidney carboxylesterase: cloning, sequencing, cellular localization and relationship to liver hydrolase B","volume":"269","author":"Yan","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tox.2015.02.007_bib0175","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1006\/abbi.1995.1121","article-title":"Rat testicular carboxylesterase: cloning sequencing, cellular localization and relationship to liver hydrolase A","volume":"316","author":"Yan","year":"1995","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.tox.2015.02.007_bib0180","series-title":"Metabolism of Drugs and Other Xenobiotics","first-page":"165","article-title":"Hydrolytic enzymes","author":"Yan","year":"2012"},{"key":"10.1016\/j.tox.2015.02.007_bib0185","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1124\/mol.107.036889","article-title":"Interleukin-6 suppresses the expression of carboxylesterases HCE1 and HCE2 through transcriptional repression","volume":"72","author":"Yang","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tox.2015.02.007_bib0190","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.bcp.2008.10.005","article-title":"Human carboxylesterases HCE1 and HCE2: ontogenic expression, inter-individual variability and differential hydrolysis of oseltamivir, aspirin, deltamethrin and permethrin","volume":"77","author":"Yang","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2015.02.007_bib0195","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/med.20014","article-title":"Towards an understanding of organic anion transporters: structure-function relationships","volume":"24","author":"You","year":"2004","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.tox.2015.02.007_bib0200","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.3109\/00498254.2012.694493","article-title":"Constitutive expression and phenobarbital modulation of drug metabolizing enzymes and related nuclear receptors in cattle liver and extra-hepatic tissues","volume":"42","author":"Zancanella","year":"2012","journal-title":"Xenobiotica"},{"key":"10.1016\/j.tox.2015.02.007_bib0205","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/clpt.2013.220","article-title":"Genetics: epigenetics and regulation of drug metabolizing cytochrome P450 enzymes","volume":"95","author":"Zanger","year":"2014","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.tox.2015.02.007_bib0210","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0090-9556(24)15127-6","article-title":"Dexamethasone differentially regulates expression of carboxylesterase genes in humans and rats","volume":"28","author":"Zhu","year":"2000","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2015.02.007_bib0215","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1124\/dmd.109.028209","article-title":"Age- and sex-related expression and activity of carboxylesterase 1 and 2 in mouse and human liver","volume":"37","author":"Zhu","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2015.02.007_bib0220","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.bbalip.2007.01.007","article-title":"Peroxisome proliferator-activated receptor structures: ligand specificity: molecular switch and interactions with regulators","volume":"1771","author":"Zoete","year":"2007","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X15000438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X15000438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:30:01Z","timestamp":1759534201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X15000438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":44,"alternative-id":["S0300483X15000438"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2015.02.007","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ontogenic expression of human carboxylesterase-2 and cytochrome P450 3A4 in liver and duodenum: Postnatal surge and organ-dependent regulation","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2015.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}